In 2022, the Danish pharmaceutical company Novo Nordisk reported that its long-acting insulin medication Levemir® had generated about **** billion Danish kroner in Greater China. After two years of launching its another long-acting insulin product Tresiba® in China, the firm had recorded a significant sales growth of the medication in 2021.
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how ÌÇÐÄÆÆ½â°æ can support your business.
Novo Nordisk. (February 6, 2023). Net sales of diabetes and obesity care medications of Novo Nordisk in Greater China in 2022, by key product (in million DKK) [Graph]. In ÌÇÐÄÆÆ½â°æ. Retrieved August 04, 2026, from /statistics/1120873/greater-china-net-sales-of-novo-nordisk-top-diabetes-care-medicines/
Novo Nordisk. "Net sales of diabetes and obesity care medications of Novo Nordisk in Greater China in 2022, by key product (in million DKK)." Chart. February 6, 2023. ÌÇÐÄÆÆ½â°æ. Accessed August 04, 2026. /statistics/1120873/greater-china-net-sales-of-novo-nordisk-top-diabetes-care-medicines/
Novo Nordisk. (2023). Net sales of diabetes and obesity care medications of Novo Nordisk in Greater China in 2022, by key product (in million DKK). ÌÇÐÄÆÆ½â°æ. ÌÇÐÄÆÆ½â°æ Inc.. Accessed: August 04, 2026. /statistics/1120873/greater-china-net-sales-of-novo-nordisk-top-diabetes-care-medicines/
Novo Nordisk. "Net Sales of Diabetes and Obesity Care Medications of Novo Nordisk in Greater China in 2022, by Key Product (in Million Dkk)." ÌÇÐÄÆÆ½â°æ, ÌÇÐÄÆÆ½â°æ Inc., 6 Feb 2023, /statistics/1120873/greater-china-net-sales-of-novo-nordisk-top-diabetes-care-medicines/
Novo Nordisk, Net sales of diabetes and obesity care medications of Novo Nordisk in Greater China in 2022, by key product (in million DKK) ÌÇÐÄÆÆ½â°æ, /statistics/1120873/greater-china-net-sales-of-novo-nordisk-top-diabetes-care-medicines/ (last visited August 04, 2026)
Net sales of diabetes and obesity care medications of Novo Nordisk in Greater China in 2022, by key product (in million DKK) [Graph], Novo Nordisk, February 6, 2023. [Online]. Available: /statistics/1120873/greater-china-net-sales-of-novo-nordisk-top-diabetes-care-medicines/